Related Experiment Video
Updated: Aug 13, 2026
Anti-Nuclear Antibody Screening Using HEp-2 Cells
Published on: June 23, 2014
Antinuclear antibodies in dermatology
M P Heffernan1, J H Do, J Mehta
1Division of Dermatology, Washington University School of Medicine, St Louis, MO 63108, USA. Mheffern@im.wustl.edu
Antinuclear antibodies (ANAs) aid in diagnosing connective tissue diseases and understanding nuclear function. Dermatologists must grasp ANA utility and limitations for accurate patient care.
Area of Science:
- Immunology
- Cell Biology
- Dermatology
Background:
- Antinuclear antibodies (ANAs) are crucial biomarkers in rheumatology and dermatology.
- Their study has advanced the understanding of nuclear structure and cellular processes.
Purpose of the Study:
- To review clinically significant ANAs and their associated diseases.
- To elucidate the diagnostic and prognostic value of ANAs in clinical practice.
Main Methods:
- Literature review of studies on antinuclear antibodies.
- Analysis of disease associations and clinical relevance of various ANA types.
Main Results:
- Specific ANAs are linked to distinct connective tissue diseases.
- Understanding ANA patterns aids in differential diagnosis and patient management.
Conclusions:
- ANAs are indispensable tools for diagnosing and managing connective tissue diseases.
- Dermatologists require comprehensive knowledge of ANA testing for optimal patient outcomes.
More Related Videos
10:05Simultaneous Distinction of Monospecific and Mixed DFS70 Patterns During ANA Screening with a Novel HEp-2 ELITE/DFS70 Knockout Substrate
Published on: January 17, 2018
10:55Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy
Published on: October 31, 2025
